123 related articles for article (PubMed ID: 2031885)
21. Preoperative assessment of the patient with breast cancer.
Baker RR
Surg Clin North Am; 1984 Dec; 64(6):1039-50. PubMed ID: 6393394
[TBL] [Abstract][Full Text] [Related]
22. Serum alkaline phosphatase determination. Value in the staging of advanced breast cancer.
White DR; Maloney JJ; Muss HB; Vance RP; Barnes P; Howard V; Rhyne L; Cowan RJ
JAMA; 1979 Sep; 242(11):1147-9. PubMed ID: 470066
[TBL] [Abstract][Full Text] [Related]
23. Imaging techniques and guidelines for evaluation and follow-up of breast cancer patients.
Feig SA
Crit Rev Diagn Imaging; 1987; 27(1):1-16. PubMed ID: 3556014
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer.
Roberts JG; Gravelle IH; Baum M; Bligh AS; Leach KG; Hughes LE
Lancet; 1976 Jan; 1(7953):237-9. PubMed ID: 55541
[TBL] [Abstract][Full Text] [Related]
25. Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations.
Nicolini A; Carpi A; Ferrari P; Pieri L
Tumour Biol; 2003; 24(6):275-80. PubMed ID: 15004486
[TBL] [Abstract][Full Text] [Related]
26. [Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].
Dose-Schwarz J; Mahner S; Schirrmacher S; Jenicke L; Müller V; Habermann CR; Brenner W
Nuklearmedizin; 2008; 47(3):97-103. PubMed ID: 18493688
[TBL] [Abstract][Full Text] [Related]
27. Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread.
Gerber B; Seitz E; Müller H; Krause A; Reimer T; Kundt G; Friese K
Breast Cancer Res Treat; 2003 Nov; 82(1):29-37. PubMed ID: 14672401
[TBL] [Abstract][Full Text] [Related]
28. 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.
Van Den Bossche B; D'haeninck E; De Winter F; Van Belle S; Dierckx RA; Van De Wiele C
Nucl Med Commun; 2004 Aug; 25(8):787-92. PubMed ID: 15266172
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Koolen BB; Vrancken Peeters MJ; Aukema TS; Vogel WV; Oldenburg HS; van der Hage JA; Hoefnagel CA; Stokkel MP; Loo CE; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
Breast Cancer Res Treat; 2012 Jan; 131(1):117-26. PubMed ID: 21935602
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy.
Arnstein NB; Harbert JC; Byrne PJ
Cancer; 1984 Nov; 54(10):2243-7. PubMed ID: 6488143
[TBL] [Abstract][Full Text] [Related]
31. The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer.
Kamby C; Guldhammer B; Vejborg I; Rossing N; Dirksen H; Daugaard S; Mouridsen HT
Cancer; 1987 Sep; 60(6):1306-12. PubMed ID: 3621113
[TBL] [Abstract][Full Text] [Related]
32. Screening for distant metastases in patients with head and neck cancer.
de Bree R; Deurloo EE; Snow GB; Leemans CR
Laryngoscope; 2000 Mar; 110(3 Pt 1):397-401. PubMed ID: 10718426
[TBL] [Abstract][Full Text] [Related]
33. Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.
Lee KH; Park JM; Yoon JK; Koh KC; Paik SW; Kim BT
Hepatogastroenterology; 2003; 50(54):1983-6. PubMed ID: 14696448
[TBL] [Abstract][Full Text] [Related]
34. Clinical and radiologic characteristics of bone metastases in breast cancer.
Kamby C; Vejborg I; Daugaard S; Guldhammer B; Dirksen H; Rossing N; Mouridsen HT
Cancer; 1987 Nov; 60(10):2524-31. PubMed ID: 3664434
[TBL] [Abstract][Full Text] [Related]
35. Detection of recurrent breast cancer.
Cowan JD; Kies MS
South Med J; 1981 Aug; 74(8):910-2. PubMed ID: 6267718
[TBL] [Abstract][Full Text] [Related]
36. Bone scintigraphy in patients with breast cancer: malignant involvement of the sternum.
Ohtake E; Murata H; Maruno H
Radiat Med; 1994; 12(1):25-8. PubMed ID: 8016400
[TBL] [Abstract][Full Text] [Related]
37. Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy.
Perez DJ; Powles TJ; Milan J; Gazet JC; Ford HT; McCready VR; MacDonald JS; Coombes RC
Lancet; 1983 Sep; 2(8350):613-6. PubMed ID: 6136757
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia.
Hanash KA; Bissada NK; Abla A; Esmail D; Dowling A
Cancer; 1984 Jul; 54(1):172-6. PubMed ID: 6232995
[TBL] [Abstract][Full Text] [Related]
39. The application of the 99Tcm phosphate bone scan to the study of breast cancer.
Citrin DL; Bessent RG; Greig WR; McKellar NJ; Furnival C; Blumgart LH
Br J Surg; 1975 Mar; 62(3):201-4. PubMed ID: 1122358
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
